Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein

Monoclonal antibodies (mAbs) play an increasing important role in the therapeutic armamentarium against multiple sclerosis (MS), an inflammatory and degenerative disorder of the central nervous system. Most of the mAbs currently developed for MS are immunomodulators blocking the inflammatory immune...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:MAbs
Päätekijät: Curtin, François, Perron, Hervé, Kromminga, Arno, Porchet, Hervé, Lang, Alois B
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2014
Aiheet:
Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623301/
https://ncbi.nlm.nih.gov/pubmed/25427053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2014.985021
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia